206 related articles for article (PubMed ID: 9508053)
21. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors.
Matsui H; Shibata M; Brown B; Labelle A; Hegadorn C; Andrews C; Hebbel RP; Galipeau J; Hough C; Lillicrap D
Stem Cells; 2007 Oct; 25(10):2660-9. PubMed ID: 17615271
[TBL] [Abstract][Full Text] [Related]
22. High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells.
Marx JC; Allay JA; Persons DA; Nooner SA; Hargrove PW; Kelly PF; Vanin EF; Horwitz EM
Hum Gene Ther; 1999 May; 10(7):1163-73. PubMed ID: 10340548
[TBL] [Abstract][Full Text] [Related]
23. Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells.
Relander T; Johansson M; Olsson K; Ikeda Y; Takeuchi Y; Collins M; Richter J
Mol Ther; 2005 Mar; 11(3):452-9. PubMed ID: 15727942
[TBL] [Abstract][Full Text] [Related]
24. Gibbon ape leukemia virus poorly replicates in primary human T lymphocytes: implications for safety testing of primary human T lymphocytes transduced with GALV-pseudotyped vectors.
Lamers CH; Willemsen RA; van Elzakker PM; Gratama JW; Debets R
J Immunother; 2009 Apr; 32(3):272-9. PubMed ID: 19242373
[TBL] [Abstract][Full Text] [Related]
25. Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A.
Doering CB; Denning G; Dooriss K; Gangadharan B; Johnston JM; Kerstann KW; McCarty DA; Spencer HT
Mol Ther; 2009 Jul; 17(7):1145-54. PubMed ID: 19259064
[TBL] [Abstract][Full Text] [Related]
26. An induced pluripotent stem cell-mediated and integration-free factor VIII expression system.
Yakura Y; Ishihara C; Kurosaki H; Kazuki Y; Komatsu N; Okada Y; Doi T; Takeya H; Oshimura M
Biochem Biophys Res Commun; 2013 Feb; 431(2):336-41. PubMed ID: 23291180
[TBL] [Abstract][Full Text] [Related]
27. Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer.
Kang Y; Xie L; Tran DT; Stein CS; Hickey M; Davidson BL; McCray PB
Blood; 2005 Sep; 106(5):1552-8. PubMed ID: 15886327
[TBL] [Abstract][Full Text] [Related]
28. Preclinical Development of a Hematopoietic Stem and Progenitor Cell Bioengineered Factor VIII Lentiviral Vector Gene Therapy for Hemophilia A.
Doering CB; Denning G; Shields JE; Fine EJ; Parker ET; Srivastava A; Lollar P; Spencer HT
Hum Gene Ther; 2018 Oct; 29(10):1183-1201. PubMed ID: 30160169
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of gibbon ape leukemia virus (GALV) receptor (GLVR1) on human CD34(+) cells increases gene transfer mediated by GALV pseudotyped vectors.
Relander T; Brun AC; Olsson K; Pedersen L; Richter J
Mol Ther; 2002 Sep; 6(3):400-6. PubMed ID: 12231177
[TBL] [Abstract][Full Text] [Related]
30. [In vivo transfection and expression of human coagulant factor VIII cDNA in mice].
Kang WY; Wang HL; Wang H; Wang XF; Wang CZ; Fu QH; Ding QL; Wu WM; Fang Y; Wang ZY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Apr; 12(2):188-93. PubMed ID: 15157331
[TBL] [Abstract][Full Text] [Related]
31. Efficient Pseudotyping of Different Retroviral Vectors Using a Novel, Codon-Optimized Gene for Chimeric GALV Envelope.
Mirow M; Schwarze LI; Fehse B; Riecken K
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452336
[TBL] [Abstract][Full Text] [Related]
32. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
33. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice.
Connelly S; Smith TA; Dhir G; Gardner JM; Mehaffey MG; Zaret KS; McClelland A; Kaleko M
Hum Gene Ther; 1995 Feb; 6(2):185-93. PubMed ID: 7537539
[TBL] [Abstract][Full Text] [Related]
34. Ex vivo selection for oncoretrovirally transduced green fluorescent protein-expressing CD34-enriched cells increases short-term engraftment of transduced cells in baboons.
Kiem HP; Rasko JE; Morris J; Peterson L; Kurre P; Andrews RG
Hum Gene Ther; 2002 May; 13(8):891-9. PubMed ID: 12031122
[TBL] [Abstract][Full Text] [Related]
35. Sustaining expression of B domain-deleted human factor VIII mediated by using lentiviral vectors in NOD/SCID mouse.
Li YJ; Chen C; Zeng LY; Cao J; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):658-63. PubMed ID: 22739177
[TBL] [Abstract][Full Text] [Related]
36. Efficient adenoviral vector transduction and expression of functional human factor VIII in cultured primary human hepatocytes.
Andrews JL; Weaver L; Kaleko M; Connelly S
Haemophilia; 1999 May; 5(3):160-8. PubMed ID: 10444282
[TBL] [Abstract][Full Text] [Related]
37. An engineered EBV vector expressing human factor VIII and von Willebrand factor in cultured B-cells.
Basu U; Banerjee S
J Gene Med; 2004 Jul; 6(7):760-8. PubMed ID: 15241783
[TBL] [Abstract][Full Text] [Related]
38. Heterogeneity of the immune response to adenovirus-mediated factor VIII gene therapy in different inbred hemophilic mouse strains.
Rawle FE; Shi CX; Brown B; McKinven A; Tinlin S; Graham FL; Hough C; Lillicrap D
J Gene Med; 2004 Dec; 6(12):1358-68. PubMed ID: 15493040
[TBL] [Abstract][Full Text] [Related]
39. Mesenchymal stem cells as vehicles for gene delivery.
Mosca JD; Hendricks JK; Buyaner D; Davis-Sproul J; Chuang LC; Majumdar MK; Chopra R; Barry F; Murphy M; Thiede MA; Junker U; Rigg RJ; Forestell SP; Böhnlein E; Storb R; Sandmaier BM
Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S71-90. PubMed ID: 11039755
[TBL] [Abstract][Full Text] [Related]
40. Adenovirus-mediated factor VIII gene expression results in attenuated anti-factor VIII-specific immunity in hemophilia A mice compared with factor VIII protein infusion.
Bristol JA; Gallo-Penn A; Andrews J; Idamakanti N; Kaleko M; Connelly S
Hum Gene Ther; 2001 Sep; 12(13):1651-61. PubMed ID: 11535168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
